As of June 03, 2025, Passage Bio (PASG) has a market cap of $28.588 million USD. According to our data, Passage Bio is ranked No.8422 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jun 03, 2025 | $28.59 M |
-18.87%
|
Dec 31, 2024 | $35.24 M |
-43.86%
|
Dec 29, 2023 | $62.77 M |
-26.81%
|
Dec 30, 2022 | $85.76 M |
-78.27%
|
Dec 31, 2021 | $0.39 B |
-75.17%
|
Dec 31, 2020 | $1.59 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() CRISPR Therapeutics
CRSP
|
$3.27 B |
-0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.15 B |
-0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.79 B |
-0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.12 B |
-0.000 M
|
![]() USA
|
![]() REGENXBIO
RGNX
|
$0.51 B |
0.000 M
|
![]() USA
|
![]() Adverum Biotechnologies
ADVM
|
$53.29 M |
0.000 M
|
![]() USA
|
![]() Rocket Pharmaceuticals
RCKT
|
$0.32 B |
-0.000 M
|
![]() USA
|
![]() uniQure
QURE
|
$0.83 B |
0.000 M
|
![]() Netherlands
|
![]() Voyager Therapeutics
VYGR
|
$0.18 B |
0.000 M
|
![]() USA
|
![]() MeiraGTx
MGTX
|
$0.45 B |
0.000 M
|
![]() USA
|
![]() Solid Biosciences
SLDB
|
$0.27 B |
0.000 M
|
![]() USA
|
![]() Generation Bio
GBIO
|
$25.96 M |
0.000 M
|
![]() USA
|
![]() Beam Therapeutics
BEAM
|
$1.69 B |
0.000 M
|
![]() USA
|
Market Cap | = | PASG Stock Price | * | PASG Shares Outstanding |
= | $0.46 | * | 62.15 M | |
= | $28.59 M |